ENTA - CIK 0001177648
The table below shows ENANTA PHARMACEUTICALS INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $32.30M | $37.23M | $85.39M | $43.99M | $57.21M | $87.13M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $6.88M | $6.65M | $8.61M | $20.32M | $23.58M | $23.49M |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $204.34M |
| $299.85M |
| $422.79M |
| $311.71M |
| $319.02M |
| $436.84M |
| Property, plant & equipment | $35.40M | $32.69M | $11.92M | $6.17M | $5.94M | $8.60M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $280.73M | $376.65M | $462.27M | $375.41M | $438.79M | $486.13M |
| Accounts payable | $1.95M | $8.00M | $4.10M | $6.00M | $9.54M | $5.74M |
| Total current liabilities | $48.55M | $57.53M | $62.79M | $29.83M | $36.17M | $24.16M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $216.01M | $247.84M | $245.54M | $54.08M | $39.36M | $30.55M |
| Retained earnings | -$404.93M | -$323.04M | -$207.00M | -$73.18M | $48.58M | $127.57M |
| Total equity | $64.72M | $128.81M | $216.74M | $321.33M | $399.43M | $455.58M |